The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Congenital Heart Defect Devices Market Over The Period 2026–2030?
The congenital heart defect devices market has experienced robust expansion in recent years. It is anticipated to increase from $3.11 billion in 2025 to $3.34 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The historical period’s growth drivers include a rising incidence of congenital heart defects, advancements made in pediatric cardiac surgery, increasing survival rates among individuals with congenital heart conditions, the expansion of specialized cardiac care centers, and a growing awareness regarding early diagnosis of congenital defects.
The congenital heart defect devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. Several factors will drive this growth during the forecast period, including a heightened emphasis on prompt diagnosis and intervention, a growing need for less invasive pediatric cardiac procedures, wider availability of sophisticated cardiac care in developing regions, an expanding demographic of adults living with congenital heart disease, and ongoing advancements in implantable cardiac devices. Key trends expected over the forecast period encompass the increasing acceptance of minimally invasive congenital heart procedures, greater utilization of transcatheter and implantable cardiac devices, a stronger focus on cardiac interventions for infants and children, the broadening of device-based treatments for intricate heart defects, and a rising requirement for long-term cardiac monitoring and support tools.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18543&type=smp
Which Major Factors Are Driving The Expansion Of The Congenital Heart Defect Devices Market?
A rising count of minimally invasive procedures is projected to fuel expansion within the congenital heart defect device market. These procedures entail surgical operations conducted via small cuts or natural bodily orifices, frequently employing specific instruments and methods to lessen injury and improve recuperation. This surge in minimally invasive procedures stems from technological progress, patient inclination towards less intrusive treatments, refined surgical methods, and the advantages of shorter recovery periods and fewer complications. Devices for congenital heart defects are utilized in minimally invasive procedures, aiding in the diagnosis, therapy, and control of cardiac irregularities via methods involving smaller cuts or catheter-based interventions. As an illustration, in June 2024, data from the American Society of Plastic Surgeons, a US-based organization, indicated that in 2023, plastic surgeries saw a 5% increase, whereas minimally invasive procedures experienced a 7% rise over the preceding year. Consequently, the growing adoption of minimally invasive procedures is propelling the congenital heart defect devices market.
How Is The Congenital Heart Defect Devices Market Divided Into Its Major Segments?
The congenital heart defect devices market covered in this report is segmented –
1) By Device Type: Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
2) By Defect Type: Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
3) By End user: Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users
Subsegments:
1) By Catheters: Balloon Catheters, Diagnostic Catheters, Guiding Catheters
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
6) By Other Device Types: Transcatheter Heart Valves, Ventricular Assist Devices (VADS)
How Are Trends Transforming The Congenital Heart Defect Devices Market Landscape?
Leading entities within the congenital heart defect devices market are engaging in strategic partnerships to create innovative devices for congenital heart defects. These collaborative arrangements support companies in the congenital heart defect devices sector by consolidating resources and expertise, boosting research and development endeavors, expanding market access, and accelerating commercialization. This teamwork ultimately nurtures innovation and stimulates progress across the industry. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, joined forces with HeartX, an India-based MedTech firm, to improve patient care within the cardiovascular sector. Through this partnership, Sahajanand Medical Technologies (SMT) strengthens its position in the congenital heart defect (CHD) space by integrating HeartX’s innovative solutions, such as the JOVE VB Stent. This strategic alliance allows SMT to offer advanced CHD devices that enhance treatment efficacy, simplify procedures, and improve patient outcomes.
Who Are The Prominent Organizations Shaping The Congenital Heart Defect Devices Market?
Major companies operating in the congenital heart defect devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc
Read the full congenital heart defect devices market report here:
Which Region Currently Holds The Largest Share Of The Congenital Heart Defect Devices Market?
North America was the largest region in the congenital heart defect devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Congenital Heart Defect Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18543&type=smp
Browse Through More Reports Similar to the Global Congenital Heart Defect Devices Market 2026, By The Business Research Company
Computed Tomography Ct Scanners Devices And Equipment Market Report 2026
Computed Tomography Ct Scanner Market Report 2026
Positron Emission Tomography Pet Scanners Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model